Daiichi eyes almost $15B in oncology sales by 2030 in ADC franchise push

Daiichi Sankyo is betting on its oncology franchise to push it past 3 trillion Japanese yen ($19 billion) in 2030 revenues. The drugmaker published a new five-year business plan on Monday ...